These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 33603169)
1. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner. Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169 [TBL] [Abstract][Full Text] [Related]
2. HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases. Kogler M; Tortola L; Negri GL; Leopoldi A; El-Naggar AM; Mereiter S; Gomez-Diaz C; Nitsch R; Tortora D; Kavirayani AM; Gapp BV; Rao S; Uribesalgo I; Hoffmann D; Cikes D; Novatchkova M; Williams DA; Trent JM; Ikeda F; Daugaard M; Hagelkruys A; Sorensen PH; Penninger JM Cancer Res; 2020 Jul; 80(14):3009-3022. PubMed ID: 32366477 [TBL] [Abstract][Full Text] [Related]
3. The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes. Turgu B; El-Naggar A; Kogler M; Tortola L; Zhang HF; Hassan M; Lizardo MM; Kung SH; Lam W; Penninger JM; Sorensen PH EMBO Rep; 2023 Dec; 24(12):e56815. PubMed ID: 37846480 [TBL] [Abstract][Full Text] [Related]
4. Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells. Kim I; Shin SH; Lee JE; Park JW Oncogene; 2019 May; 38(19):3651-3666. PubMed ID: 30659265 [TBL] [Abstract][Full Text] [Related]
5. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation. Castillo-Lluva S; Tan CT; Daugaard M; Sorensen PH; Malliri A Oncogene; 2013 Mar; 32(13):1735-42. PubMed ID: 22614015 [TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1. Torrino S; Visvikis O; Doye A; Boyer L; Stefani C; Munro P; Bertoglio J; Gacon G; Mettouchi A; Lemichez E Dev Cell; 2011 Nov; 21(5):959-65. PubMed ID: 22036506 [TBL] [Abstract][Full Text] [Related]
8. HACE1, an E3 Ubiquitin Protein Ligase, Mitigates Kaposi's Sarcoma-Associated Herpesvirus Infection-Induced Oxidative Stress by Promoting Nrf2 Activity. Kumar B; Roy A; Asha K; Sharma-Walia N; Ansari MA; Chandran B J Virol; 2019 May; 93(9):. PubMed ID: 30787155 [TBL] [Abstract][Full Text] [Related]
9. Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression. Li JC; Chang X; Chen Y; Li XZ; Zhang XL; Yang SM; Hu CJ; Zhang H Curr Drug Targets; 2019; 20(10):1018-1028. PubMed ID: 30827236 [TBL] [Abstract][Full Text] [Related]
10. HACE1 negatively regulates neuroinflammation through ubiquitylating and degrading Rac1 in Parkinson's disease models. Zang CX; Wang L; Yang HY; Shang JM; Liu H; Zhang ZH; Ju C; Yuan FY; Li FY; Bao XQ; Zhang D Acta Pharmacol Sin; 2022 Feb; 43(2):285-294. PubMed ID: 34593974 [TBL] [Abstract][Full Text] [Related]
11. HACE1 is a potential tumor suppressor in osteosarcoma. El-Naggar AM; Clarkson PW; Negri GL; Turgu B; Zhang F; Anglesio MS; Sorensen PH Cell Death Dis; 2019 Jan; 10(1):21. PubMed ID: 30622235 [TBL] [Abstract][Full Text] [Related]
12. Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression. Goka ET; Lippman ME Oncogene; 2015 Oct; 34(42):5395-405. PubMed ID: 25659579 [TBL] [Abstract][Full Text] [Related]
13. Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation. Andrio E; Lotte R; Hamaoui D; Cherfils J; Doye A; Daugaard M; Sorensen PH; Bost F; Ruimy R; Mettouchi A; Lemichez E Sci Rep; 2017 Mar; 7():44779. PubMed ID: 28317937 [TBL] [Abstract][Full Text] [Related]
14. HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress. Zhang L; Chen X; Sharma P; Moon M; Sheftel AD; Dawood F; Nghiem MP; Wu J; Li RK; Gramolini AO; Sorensen PH; Penninger JM; Brumell JH; Liu PP Nat Commun; 2014 Mar; 5():3430. PubMed ID: 24614889 [TBL] [Abstract][Full Text] [Related]
15. Structural Basis for the Enzymatic Activity of the HACE1 HECT-Type E3 Ligase Through N-Terminal Helix Dimerization. Singh S; Machida S; Tulsian NK; Choong YK; Ng J; Shankar S; Liu Y; Chandiramani KV; Shi J; Sivaraman J Adv Sci (Weinh); 2023 Sep; 10(27):e2207672. PubMed ID: 37537642 [TBL] [Abstract][Full Text] [Related]
16. Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells. El-Hachem N; Habel N; Naiken T; Bzioueche H; Cheli Y; Beranger GE; Jaune E; Rouaud F; Nottet N; Reinier F; Gaudel C; Colosetti P; Bertolotto C; Ballotti R Cell Death Differ; 2018 Nov; 25(11):2010-2022. PubMed ID: 29515254 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of esophageal cancer progression through HACE1-TRIP12 interaction and associated RAC1 ubiquitination and degradation. Hu Y; Zhu Z; Xu Y; Zaman MF; Ge Y; Hu J; Tang X J Cancer; 2024; 15(10):3114-3127. PubMed ID: 38706891 [No Abstract] [Full Text] [Related]
18. Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction. Cetinbas N; Daugaard M; Mullen AR; Hajee S; Rotblat B; Lopez A; Li A; DeBerardinis RJ; Sorensen PH Oncogene; 2015 Jul; 34(30):4005-10. PubMed ID: 25284589 [TBL] [Abstract][Full Text] [Related]
19. Group-I PAKs-mediated phosphorylation of HACE1 at serine 385 regulates its oligomerization state and Rac1 ubiquitination. Acosta MI; Urbach S; Doye A; Ng YW; Boudeau J; Mettouchi A; Debant A; Manser E; Visvikis O; Lemichez E Sci Rep; 2018 Jan; 8(1):1410. PubMed ID: 29362425 [TBL] [Abstract][Full Text] [Related]